Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 135
Titolo Data di pubblicazione Autore(i) File
Surgical treatment of primitive thyroid lymphoma 2009 Avenia, Nicola; Ragusa, Mark; Cirocchi, Roberto; Puxeddu, Efisio; Cavaliere, Antonio; DE FEO, Pierpaolo; Sidoni, Angelo; Roila, F.; Sanguinetti, A.; Puma, Francesco
Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations 2009 Peterson, De; Bensadoun, Rj; Roila, F
Hematopoietic growth factors: ESMO Recommendations for the applications 2009 Crawford, J; Caserta, C; Roila, F
Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use 2009 Scrijvers, D; Roila, F
Management of cancer pain: ESMO Clinical Recommendations 2009 Jost, L; Roila, F
Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis 2009 Herrstedt, J; Roila, F
Primitive thyroid lymphomas 2009 D'Ajello, Fabio; Calzolari, F.; Galasse, S.; Lucchini, R.; Monacelli, M.; Sanguinetti, A.; D'Ajello, M.; Avenia, Nicola; Roila, Fausto
Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up 2009 Stupp, R; Roila, F
Treatment of Lung Cancer 2009 Ballatori, E; Fatigoni, S; Roila, F
Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy 2009 Herrstedt, J; Apornwirat, W; Shaharyar, A; Aziz, Z; Roila, F; Van Belle, S; Russo, Mw; Levin, J; Ranganathan, S; Guckert, M; Grunberg, Sm
Comparison of palonosetron (PALO) plus dexamethasone on day 1, with or without dexamethasone on days 2 and 3, in the prevention of chemotherapy induced nausea and vomiting (CINV) in breast cancer patients treated with anthracycline/cyclophosphamide regimens 2009 Fabi, A; Nole, F; Roila, F; Medici, M; Steger, G; Bachmann, C; Roncoroni, S; Ballinari, G
Palonosetron (PALO) plus dexamethasone (DEX) administered on day only prevents emesis and avoids prolonged DEX use in breast cancer patients treated with anthracycline/cyclophosphamide regimens 2009 Aapro, M; Misset, J; Fabi, A; Steger, G; Bachmann, C; Roila, F; Roncoroni, S
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. 2009 Bartolucci, R.; ., ; Perez, Roca; L., .; Puma, Francesco; Farabi, R; Roila, F; Taron, M; Rosell, R.
Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literature 2010 Sanguinetti, A.; Ragusa, Mark; Calzolari, F.; D'Ajello, F.; Fioriti, L.; Papini, D.; Sidoni, Angelo; Roila, F.; Avenia, Nicola
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference 2010 Roila, F; Herrstedt, J; Aapro, M; Gralla, Rj; Einhorn, Lh; Ballatori, E; Bria, E; Clark-Snow, Ra; Espersen, Bt; Feyer, P; Grunberg, Sm; Hesketh, Pj; Jordan, K; Kris, Mg; Maranzano, E; Molassiotis, A; Morrow, G; Olver, I; Rapoport, Bl; Rittenberg, C; Saito, M; Tonato, M; Warr, D
Prevention and treatment of pandemic influenza in cancer patients. 2010 Francisci, Daniela; Labianca, R; Roila, Fausto
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management 2010 Mandala, M; Falanga, A; Roila, F
Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use 2010 Schrijvers, D; De Samblanx, H; Roila, F
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy 2010 Aapro, M; Fabi, A; Nole, F; Medici, M; Steger, G; Bachmann, C; Roncoroni, S; Roila, F
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines 2010 Bovelli, D; Plataniotis, G; Roila, F
Mostrati risultati da 21 a 40 di 135
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile